APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-benzodiazepine Hypnotics

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Non-benzodiazepine Hypnotics Market Analysis and Forecast 2026-2032

30 December 2025214 pages

Choose your research edition.

Industry ResearchNon-benzodiazepine Hypnotics Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-benzodiazepine Hypnotics Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal Non-benzodiazepine Hypnotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-benzodiazepine Hypnotics Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-benzodiazepine Hypnotics Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Non-benzodiazepine Hypnotics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Non-benzodiazepine Hypnotics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Non-benzodiazepine Hypnotics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Non-benzodiazepine Hypnotics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Non-benzodiazepine Hypnotics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Non-benzodiazepine Hypnotics include Abbott, Tianjin Tasly Saint Pharmaceuticals, Sun Pharmaceutical, Shanghai Pharmaceuticals, Qilu Pharmaceutical, Kanghong Pharmaceuticals, Changzhou Siyao Pharmaceutical, Wockhardt and Torrent Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Non-benzodiazepine Hypnotics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Non-benzodiazepine Hypnotics, also provides the sales of main regions and countries. Of the upcoming market potential for Non-benzodiazepine Hypnotics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Non-benzodiazepine Hypnotics sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Non-benzodiazepine Hypnotics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Non-benzodiazepine Hypnotics sales, projected growth trends, production technology, application and end-user industry.

Non-benzodiazepine Hypnotics Segment by Company

Abbott

Tianjin Tasly Saint Pharmaceuticals

Sun Pharmaceutical

Shanghai Pharmaceuticals

Qilu Pharmaceutical

Kanghong Pharmaceuticals

Changzhou Siyao Pharmaceutical

Wockhardt

Torrent Pharma

Teva Pharmaceuticals

Tapi Teva

Sanofi-aventis

Northstar Rx

Mylan Pharmaceuticals

Kanghong Pharmaceutical

Hikma Pharmaceuticals

Glenmark Life Sciences

Endo

Dr. Reddy’s Laboratories

Centaur Pharmaceuticals

Apotex

Admiron Life

Non-benzodiazepine Hypnotics Segment by Type

Zaleplon

Zopiclone

Zolpidem

Other

Non-benzodiazepine Hypnotics Segment by Application

Hospital

Clinic

Other

Non-benzodiazepine Hypnotics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-benzodiazepine Hypnotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-benzodiazepine Hypnotics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-benzodiazepine Hypnotics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Non-benzodiazepine Hypnotics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Non-benzodiazepine Hypnotics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-benzodiazepine Hypnotics sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Non-benzodiazepine Hypnotics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Zaleplon Major Manufacturers Table 3. Zopiclone Major Manufacturers Table 4. Zolpidem Major Manufacturers Table 5. Other Major Manufacturers Table 6. Global Non-benzodiazepine Hypnotics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Manufacturers Table 8. Clinic Major Manufacturers Table 9. Other Major Manufacturers Table 10. Non-benzodiazepine Hypnotics Industry Trends Table 11. Non-benzodiazepine Hypnotics Industry Drivers Table 12. Non-benzodiazepine Hypnotics Industry Opportunities and Challenges Table 13. Non-benzodiazepine Hypnotics Industry Restraints Table 14. Global Non-benzodiazepine Hypnotics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Non-benzodiazepine Hypnotics Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Non-benzodiazepine Hypnotics Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Non-benzodiazepine Hypnotics Revenue Market Share by Region (2021-2026) Table 18. Global Non-benzodiazepine Hypnotics Revenue Market Share by Region (2027-2032) Table 19. Global Non-benzodiazepine Hypnotics Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Non-benzodiazepine Hypnotics Sales by Region (2021-2026) & (K Units) Table 21. Global Non-benzodiazepine Hypnotics Sales by Region (2027-2032) & (K Units) Table 22. Global Non-benzodiazepine Hypnotics Sales Market Share by Region (2021-2026) Table 23. Global Non-benzodiazepine Hypnotics Sales Market Share by Region (2027-2032) Table 24. Global Non-benzodiazepine Hypnotics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Non-benzodiazepine Hypnotics Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Non-benzodiazepine Hypnotics Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Non-benzodiazepine Hypnotics Sales Market Share by Manufacturers (2021-2026) Table 28. Global Non-benzodiazepine Hypnotics Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Non-benzodiazepine Hypnotics Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Non-benzodiazepine Hypnotics Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Non-benzodiazepine Hypnotics Manufacturers, Product Type & Application Table 32. Global Non-benzodiazepine Hypnotics Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Non-benzodiazepine Hypnotics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Non-benzodiazepine Hypnotics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Non-benzodiazepine Hypnotics Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Non-benzodiazepine Hypnotics Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Non-benzodiazepine Hypnotics Revenue Market Share by Type (2021-2026) Table 39. Global Non-benzodiazepine Hypnotics Revenue Market Share by Type (2027-2032) Table 40. Global Non-benzodiazepine Hypnotics Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Non-benzodiazepine Hypnotics Sales by Type (2021-2026) & (K Units) Table 42. Global Non-benzodiazepine Hypnotics Sales by Type (2027-2032) & (K Units) Table 43. Global Non-benzodiazepine Hypnotics Sales Market Share by Type (2021-2026) Table 44. Global Non-benzodiazepine Hypnotics Sales Market Share by Type (2027-2032) Table 45. Global Non-benzodiazepine Hypnotics Price by Type (2021-2026) & (US$/Unit) Table 46. Global Non-benzodiazepine Hypnotics Price by Type (2027-2032) & (US$/Unit) Table 47. Global Non-benzodiazepine Hypnotics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Non-benzodiazepine Hypnotics Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Non-benzodiazepine Hypnotics Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Non-benzodiazepine Hypnotics Revenue Market Share by Application (2021-2026) Table 51. Global Non-benzodiazepine Hypnotics Revenue Market Share by Application (2027-2032) Table 52. Global Non-benzodiazepine Hypnotics Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Non-benzodiazepine Hypnotics Sales by Application (2021-2026) & (K Units) Table 54. Global Non-benzodiazepine Hypnotics Sales by Application (2027-2032) & (K Units) Table 55. Global Non-benzodiazepine Hypnotics Sales Market Share by Application (2021-2026) Table 56. Global Non-benzodiazepine Hypnotics Sales Market Share by Application (2027-2032) Table 57. Global Non-benzodiazepine Hypnotics Price by Application (2021-2026) & (US$/Unit) Table 58. Global Non-benzodiazepine Hypnotics Price by Application (2027-2032) & (US$/Unit) Table 59. Abbott Company Information Table 60. Abbott Business Overview Table 61. Abbott Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Abbott Non-benzodiazepine Hypnotics Product Portfolio Table 63. Abbott Recent Development Table 64. Tianjin Tasly Saint Pharmaceuticals Company Information Table 65. Tianjin Tasly Saint Pharmaceuticals Business Overview Table 66. Tianjin Tasly Saint Pharmaceuticals Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Tianjin Tasly Saint Pharmaceuticals Non-benzodiazepine Hypnotics Product Portfolio Table 68. Tianjin Tasly Saint Pharmaceuticals Recent Development Table 69. Sun Pharmaceutical Company Information Table 70. Sun Pharmaceutical Business Overview Table 71. Sun Pharmaceutical Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Sun Pharmaceutical Non-benzodiazepine Hypnotics Product Portfolio Table 73. Sun Pharmaceutical Recent Development Table 74. Shanghai Pharmaceuticals Company Information Table 75. Shanghai Pharmaceuticals Business Overview Table 76. Shanghai Pharmaceuticals Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Shanghai Pharmaceuticals Non-benzodiazepine Hypnotics Product Portfolio Table 78. Shanghai Pharmaceuticals Recent Development Table 79. Qilu Pharmaceutical Company Information Table 80. Qilu Pharmaceutical Business Overview Table 81. Qilu Pharmaceutical Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Qilu Pharmaceutical Non-benzodiazepine Hypnotics Product Portfolio Table 83. Qilu Pharmaceutical Recent Development Table 84. Kanghong Pharmaceuticals Company Information Table 85. Kanghong Pharmaceuticals Business Overview Table 86. Kanghong Pharmaceuticals Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Kanghong Pharmaceuticals Non-benzodiazepine Hypnotics Product Portfolio Table 88. Kanghong Pharmaceuticals Recent Development Table 89. Changzhou Siyao Pharmaceutical Company Information Table 90. Changzhou Siyao Pharmaceutical Business Overview Table 91. Changzhou Siyao Pharmaceutical Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Changzhou Siyao Pharmaceutical Non-benzodiazepine Hypnotics Product Portfolio Table 93. Changzhou Siyao Pharmaceutical Recent Development Table 94. Wockhardt Company Information Table 95. Wockhardt Business Overview Table 96. Wockhardt Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Wockhardt Non-benzodiazepine Hypnotics Product Portfolio Table 98. Wockhardt Recent Development Table 99. Torrent Pharma Company Information Table 100. Torrent Pharma Business Overview Table 101. Torrent Pharma Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Torrent Pharma Non-benzodiazepine Hypnotics Product Portfolio Table 103. Torrent Pharma Recent Development Table 104. Teva Pharmaceuticals Company Information Table 105. Teva Pharmaceuticals Business Overview Table 106. Teva Pharmaceuticals Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Teva Pharmaceuticals Non-benzodiazepine Hypnotics Product Portfolio Table 108. Teva Pharmaceuticals Recent Development Table 109. Tapi Teva Company Information Table 110. Tapi Teva Business Overview Table 111. Tapi Teva Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Tapi Teva Non-benzodiazepine Hypnotics Product Portfolio Table 113. Tapi Teva Recent Development Table 114. Sanofi-aventis Company Information Table 115. Sanofi-aventis Business Overview Table 116. Sanofi-aventis Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Sanofi-aventis Non-benzodiazepine Hypnotics Product Portfolio Table 118. Sanofi-aventis Recent Development Table 119. Northstar Rx Company Information Table 120. Northstar Rx Business Overview Table 121. Northstar Rx Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Northstar Rx Non-benzodiazepine Hypnotics Product Portfolio Table 123. Northstar Rx Recent Development Table 124. Mylan Pharmaceuticals Company Information Table 125. Mylan Pharmaceuticals Business Overview Table 126. Mylan Pharmaceuticals Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Mylan Pharmaceuticals Non-benzodiazepine Hypnotics Product Portfolio Table 128. Mylan Pharmaceuticals Recent Development Table 129. Kanghong Pharmaceutical Company Information Table 130. Kanghong Pharmaceutical Business Overview Table 131. Kanghong Pharmaceutical Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Kanghong Pharmaceutical Non-benzodiazepine Hypnotics Product Portfolio Table 133. Kanghong Pharmaceutical Recent Development Table 134. Hikma Pharmaceuticals Company Information Table 135. Hikma Pharmaceuticals Business Overview Table 136. Hikma Pharmaceuticals Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Hikma Pharmaceuticals Non-benzodiazepine Hypnotics Product Portfolio Table 138. Hikma Pharmaceuticals Recent Development Table 139. Glenmark Life Sciences Company Information Table 140. Glenmark Life Sciences Business Overview Table 141. Glenmark Life Sciences Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Glenmark Life Sciences Non-benzodiazepine Hypnotics Product Portfolio Table 143. Glenmark Life Sciences Recent Development Table 144. Endo Company Information Table 145. Endo Business Overview Table 146. Endo Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Endo Non-benzodiazepine Hypnotics Product Portfolio Table 148. Endo Recent Development Table 149. Dr. Reddy’s Laboratories Company Information Table 150. Dr. Reddy’s Laboratories Business Overview Table 151. Dr. Reddy’s Laboratories Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Dr. Reddy’s Laboratories Non-benzodiazepine Hypnotics Product Portfolio Table 153. Dr. Reddy’s Laboratories Recent Development Table 154. Centaur Pharmaceuticals Company Information Table 155. Centaur Pharmaceuticals Business Overview Table 156. Centaur Pharmaceuticals Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Centaur Pharmaceuticals Non-benzodiazepine Hypnotics Product Portfolio Table 158. Centaur Pharmaceuticals Recent Development Table 159. Apotex Company Information Table 160. Apotex Business Overview Table 161. Apotex Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. Apotex Non-benzodiazepine Hypnotics Product Portfolio Table 163. Apotex Recent Development Table 164. Admiron Life Company Information Table 165. Admiron Life Business Overview Table 166. Admiron Life Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 167. Admiron Life Non-benzodiazepine Hypnotics Product Portfolio Table 168. Admiron Life Recent Development Table 169. North America Non-benzodiazepine Hypnotics Revenue by Type (2021-2026) & (US$ Million) Table 170. North America Non-benzodiazepine Hypnotics Revenue by Type (2027-2032) & (US$ Million) Table 171. North America Non-benzodiazepine Hypnotics Sales by Type (2021-2026) & (K Units) Table 172. North America Non-benzodiazepine Hypnotics Sales by Type (2027-2032) & (K Units) Table 173. North America Non-benzodiazepine Hypnotics Sales Price by Type (2021-2026) & (US$/Unit) Table 174. North America Non-benzodiazepine Hypnotics Sales Price by Type (2027-2032) & (US$/Unit) Table 175. North America Non-benzodiazepine Hypnotics Revenue by Application (2021-2026) & (US$ Million) Table 176. North America Non-benzodiazepine Hypnotics Revenue by Application (2027-2032) & (US$ Million) Table 177. North America Non-benzodiazepine Hypnotics Sales by Application (2021-2026) & (K Units) Table 178. North America Non-benzodiazepine Hypnotics Sales by Application (2027-2032) & (K Units) Table 179. North America Non-benzodiazepine Hypnotics Sales Price by Application (2021-2026) & (US$/Unit) Table 180. North America Non-benzodiazepine Hypnotics Sales Price by Application (2027-2032) & (US$/Unit) Table 181. North America Non-benzodiazepine Hypnotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 182. North America Non-benzodiazepine Hypnotics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 183. North America Non-benzodiazepine Hypnotics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 184. North America Non-benzodiazepine Hypnotics Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 185. North America Non-benzodiazepine Hypnotics Sales by Country (2021-2026) & (K Units) Table 186. North America Non-benzodiazepine Hypnotics Sales by Country (2027-2032) & (K Units) Table 187. North America Non-benzodiazepine Hypnotics Sales Price by Country (2021-2026) & (US$/Unit) Table 188. North America Non-benzodiazepine Hypnotics Sales Price by Country (2027-2032) & (US$/Unit) Table 189. United States Non-benzodiazepine Hypnotics Revenue (2021-2032) & (US$ Million) Table 190. Canada Non-benzodiazepine Hypnotics Revenue (2021-2032) & (US$ Million) Table 191. Europe Non-benzodiazepine Hypnotics Revenue by Type (2021-2026) & (US$ Million) Table 192. Europe Non-benzodiazepine Hypnotics Revenue by Type (2027-2032) & (US$ Million) Table 193. Europe Non-benzodiazepine Hypnotics Sales by Type (2021-2026) & (K Units) Table 194. Europe Non-benzodiazepine Hypnotics Sales by Type (2027-2032) & (K Units) Table 195. Europe Non-benzodiazepine Hypnotics Sales Price by Type (2021-2026) & (US$/Unit) Table 196. Europe Non-benzodiazepine Hypnotics Sales Price by Type (2027-2032) & (US$/Unit) Table 197. Europe Non-benzodiazepine Hypnotics Revenue by Application (2021-2026) & (US$ Million) Table 198. Europe Non-benzodiazepine Hypnotics Revenue by Application (2027-2032) & (US$ Million) Table 199. Europe Non-benzodiazepine Hypnotics Sales by Application (2021-2026) & (K Units) Table 200. Europe Non-benzodiazepine Hypnotics Sales by Application (2027-2032) & (K Units) Table 201. Europe Non-benzodiazepine Hypnotics Sales Price by Application (2021-2026) & (US$/Unit) Table 202. Europe Non-benzodiazepine Hypnotics Sales Price by Application (2027-2032) & (US$/Unit) Table 203. Europe Non-benzodiazepine Hypnotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 204. Europe Non-benzodiazepine Hypnotics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 205. Europe Non-benzodiazepine Hypnotics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 206. Europe Non-benzodiazepine Hypnotics Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 207. Europe Non-benzodiazepine Hypnotics Sales by Country (2021-2026) & (K Units) Table 208. Europe Non-benzodiazepine Hypnotics Sales by Country (2027-2032) & (K Units) Table 209. Europe Non-benzodiazepine Hypnotics Sales Price by Country (2021-2026) & (US$/Unit) Table 210. Europe Non-benzodiazepine Hypnotics Sales Price by Country (2027-2032) & (US$/Unit) Table 211. Germany Non-benzodiazepine Hypnotics Revenue (2021-2032) & (US$ Million) Table 212. France Non-benzodiazepine Hypnotics Revenue (2021-2032) & (US$ Million) Table 213. U.K. Non-benzodiazepine Hypnotics Revenue (2021-2032) & (US$ Million) Table 214. Italy Non-benzodiazepine Hypnotics Revenue (2021-2032) & (US$ Million) Table 215. Netherlands Non-benzodiazepine Hypnotics Revenue (2021-2032) & (US$ Million) Table 216. China Non-benzodiazepine Hypnotics Revenue by Type (2021-2026) & (US$ Million) Table 217. China Non-benzodiazepine Hypnotics Revenue by Type (2027-2032) & (US$ Million) Table 218. China Non-benzodiazepine Hypnotics Sales by Type (2021-2026) & (K Units) Table 219. China Non-benzodiazepine Hypnotics Sales by Type (2027-2032) & (K Units) Table 220. China Non-benzodiazepine Hypnotics Sales Price by Type (2021-2026) & (US$/Unit) Table 221. China Non-benzodiazepine Hypnotics Sales Price by Type (2027-2032) & (US$/Unit) Table 222. China Non-benzodiazepine Hypnotics Revenue by Application (2021-2026) & (US$ Million) Table 223. China Non-benzodiazepine Hypnotics Revenue by Application (2027-2032) & (US$ Million) Table 224. China Non-benzodiazepine Hypnotics Sales by Application (2021-2026) & (K Units) Table 225. China Non-benzodiazepine Hypnotics Sales by Application (2027-2032) & (K Units) Table 226. China Non-benzodiazepine Hypnotics Sales Price by Application (2021-2026) & (US$/Unit) Table 227. China Non-benzodiazepine Hypnotics Sales Price by Application (2027-2032) & (US$/Unit) Table 228. Asia Non-benzodiazepine Hypnotics Revenue by Type (2021-2026) & (US$ Million) Table 229. Asia Non-benzodiazepine Hypnotics Revenue by Type (2027-2032) & (US$ Million) Table 230. Asia Non-benzodiazepine Hypnotics Sales by Type (2021-2026) & (K Units) Table 231. Asia Non-benzodiazepine Hypnotics Sales by Type (2027-2032) & (K Units) Table 232. Asia Non-benzodiazepine Hypnotics Sales Price by Type (2021-2026) & (US$/Unit) Table 233. Asia Non-benzodiazepine Hypnotics Sales Price by Type (2027-2032) & (US$/Unit) Table 234. Asia Non-benzodiazepine Hypnotics Revenue by Application (2021-2026) & (US$ Million) Table 235. Asia Non-benzodiazepine Hypnotics Revenue by Application (2027-2032) & (US$ Million) Table 236. Asia Non-benzodiazepine Hypnotics Sales by Application (2021-2026) & (K Units) Table 237. Asia Non-benzodiazepine Hypnotics Sales by Application (2027-2032) & (K Units) Table 238. Asia Non-benzodiazepine Hypnotics Sales Price by Application (2021-2026) & (US$/Unit) Table 239. Asia Non-benzodiazepine Hypnotics Sales Price by Application (2027-2032) & (US$/Unit) Table 240. Asia Non-benzodiazepine Hypnotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 241. Asia Non-benzodiazepine Hypnotics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 242. Asia Non-benzodiazepine Hypnotics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 243. Asia Non-benzodiazepine Hypnotics Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 244. Asia Non-benzodiazepine Hypnotics Sales by Country (2021-2026) & (K Units) Table 245. Asia Non-benzodiazepine Hypnotics Sales by Country (2027-2032) & (K Units) Table 246. Asia Non-benzodiazepine Hypnotics Sales Price by Country (2021-2026) & (US$/Unit) Table 247. Asia Non-benzodiazepine Hypnotics Sales Price by Country (2027-2032) & (US$/Unit) Table 248. Japan Non-benzodiazepine Hypnotics Revenue (2021-2032) & (US$ Million) Table 249. South Korea Non-benzodiazepine Hypnotics Revenue (2021-2032) & (US$ Million) Table 250. India Non-benzodiazepine Hypnotics Revenue (2021-2032) & (US$ Million) Table 251. Australia Non-benzodiazepine Hypnotics Revenue (2021-2032) & (US$ Million) Table 252. China Taiwan Non-benzodiazepine Hypnotics Revenue (2021-2032) & (US$ Million) Table 253. Southeast Asia Non-benzodiazepine Hypnotics Revenue (2021-2032) & (US$ Million) Table 254. SAMEA Non-benzodiazepine Hypnotics Revenue by Type (2021-2026) & (US$ Million) Table 255. SAMEA Non-benzodiazepine Hypnotics Revenue by Type (2027-2032) & (US$ Million) Table 256. SAMEA Non-benzodiazepine Hypnotics Sales by Type (2021-2026) & (K Units) Table 257. SAMEA Non-benzodiazepine Hypnotics Sales by Type (2027-2032) & (K Units) Table 258. SAMEA Non-benzodiazepine Hypnotics Sales Price by Type (2021-2026) & (US$/Unit) Table 259. SAMEA Non-benzodiazepine Hypnotics Sales Price by Type (2027-2032) & (US$/Unit) Table 260. SAMEA Non-benzodiazepine Hypnotics Revenue by Application (2021-2026) & (US$ Million) Table 261. SAMEA Non-benzodiazepine Hypnotics Revenue by Application (2027-2032) & (US$ Million) Table 262. SAMEA Non-benzodiazepine Hypnotics Sales by Application (2021-2026) & (K Units) Table 263. SAMEA Non-benzodiazepine Hypnotics Sales by Application (2027-2032) & (K Units) Table 264. SAMEA Non-benzodiazepine Hypnotics Sales Price by Application (2021-2026) & (US$/Unit) Table 265. SAMEA Non-benzodiazepine Hypnotics Sales Price by Application (2027-2032) & (US$/Unit) Table 266. SAMEA Non-benzodiazepine Hypnotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 267. SAMEA Non-benzodiazepine Hypnotics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 268. SAMEA Non-benzodiazepine Hypnotics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 269. SAMEA Non-benzodiazepine Hypnotics Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 270. SAMEA Non-benzodiazepine Hypnotics Sales by Country (2021-2026) & (K Units) Table 271. SAMEA Non-benzodiazepine Hypnotics Sales by Country (2027-2032) & (K Units) Table 272. SAMEA Non-benzodiazepine Hypnotics Sales Price by Country (2021-2026) & (US$/Unit) Table 273. SAMEA Non-benzodiazepine Hypnotics Sales Price by Country (2027-2032) & (US$/Unit) Table 274. Brazil Non-benzodiazepine Hypnotics Revenue (2021-2032) & (US$ Million) Table 275. Argentina Non-benzodiazepine Hypnotics Revenue (2021-2032) & (US$ Million) Table 276. Chile Non-benzodiazepine Hypnotics Revenue (2021-2032) & (US$ Million) Table 277. Colombia Non-benzodiazepine Hypnotics Revenue (2021-2032) & (US$ Million) Table 278. Peru Non-benzodiazepine Hypnotics Revenue (2021-2032) & (US$ Million) Table 279. Saudi Arabia Non-benzodiazepine Hypnotics Revenue (2021-2032) & (US$ Million) Table 280. Israel Non-benzodiazepine Hypnotics Revenue (2021-2032) & (US$ Million) Table 281. UAE Non-benzodiazepine Hypnotics Revenue (2021-2032) & (US$ Million) Table 282. Turkey Non-benzodiazepine Hypnotics Revenue (2021-2032) & (US$ Million) Table 283. Iran Non-benzodiazepine Hypnotics Revenue (2021-2032) & (US$ Million) Table 284. Egypt Non-benzodiazepine Hypnotics Revenue (2021-2032) & (US$ Million) Table 285. Key Raw Materials Table 286. Raw Materials Key Suppliers Table 287. Non-benzodiazepine Hypnotics Distributors List Table 288. Non-benzodiazepine Hypnotics Customers List Table 289. Research Programs/Design for This Report Table 290. Authors List of This Report Table 291. Secondary Sources Table 292. Primary Sources List of Figures Figure 1. Non-benzodiazepine Hypnotics Image Figure 2. Global Non-benzodiazepine Hypnotics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-benzodiazepine Hypnotics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Zaleplon Image Figure 5. Zopiclone Image Figure 6. Zolpidem Image Figure 7. Other Image Figure 8. Global Non-benzodiazepine Hypnotics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Non-benzodiazepine Hypnotics Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Other Image Figure 13. Global Non-benzodiazepine Hypnotics Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Non-benzodiazepine Hypnotics Revenue (2021-2032) & (US$ Million) Figure 15. Global Non-benzodiazepine Hypnotics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Non-benzodiazepine Hypnotics Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Non-benzodiazepine Hypnotics Revenue Market Share by Region (2021-2032) Figure 18. Global Non-benzodiazepine Hypnotics Sales (2021-2032) & (K Units) Figure 19. Global Non-benzodiazepine Hypnotics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Non-benzodiazepine Hypnotics Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Non-benzodiazepine Hypnotics Sales YoY (2021-2032) & (K Units) Figure 22. Europe Non-benzodiazepine Hypnotics Sales YoY (2021-2032) & (K Units) Figure 23. China Non-benzodiazepine Hypnotics Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Non-benzodiazepine Hypnotics Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Non-benzodiazepine Hypnotics Sales YoY (2021-2032) & (K Units) Figure 26. Global Non-benzodiazepine Hypnotics Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Non-benzodiazepine Hypnotics Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Non-benzodiazepine Hypnotics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Non-benzodiazepine Hypnotics Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Non-benzodiazepine Hypnotics Revenue Market Share by Type (2021-2032) Figure 32. Global Non-benzodiazepine Hypnotics Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Non-benzodiazepine Hypnotics Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Non-benzodiazepine Hypnotics Sales Market Share by Type (2021-2032) Figure 35. Global Non-benzodiazepine Hypnotics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Non-benzodiazepine Hypnotics Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Non-benzodiazepine Hypnotics Revenue Market Share by Application (2021-2032) Figure 38. Global Non-benzodiazepine Hypnotics Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Non-benzodiazepine Hypnotics Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Non-benzodiazepine Hypnotics Sales Market Share by Application (2021-2032) Figure 41. North America Non-benzodiazepine Hypnotics Revenue Share by Type (2021-2032) Figure 42. North America Non-benzodiazepine Hypnotics Sales Share by Type (2021-2032) Figure 43. North America Non-benzodiazepine Hypnotics Revenue Share by Application (2021-2032) Figure 44. North America Non-benzodiazepine Hypnotics Sales Share by Application (2021-2032) Figure 45. North America Non-benzodiazepine Hypnotics Revenue Share by Country (2021-2032) Figure 46. North America Non-benzodiazepine Hypnotics Sales Share by Country (2021-2032) Figure 47. Europe Non-benzodiazepine Hypnotics Revenue Share by Type (2021-2032) Figure 48. Europe Non-benzodiazepine Hypnotics Sales Share by Type (2021-2032) Figure 49. Europe Non-benzodiazepine Hypnotics Revenue Share by Application (2021-2032) Figure 50. Europe Non-benzodiazepine Hypnotics Sales Share by Application (2021-2032) Figure 51. Europe Non-benzodiazepine Hypnotics Revenue Share by Country (2021-2032) Figure 52. Europe Non-benzodiazepine Hypnotics Sales Share by Country (2021-2032) Figure 53. China Non-benzodiazepine Hypnotics Revenue Share by Type (2021-2032) Figure 54. China Non-benzodiazepine Hypnotics Sales Share by Type (2021-2032) Figure 55. China Non-benzodiazepine Hypnotics Revenue Share by Application (2021-2032) Figure 56. China Non-benzodiazepine Hypnotics Sales Share by Application (2021-2032) Figure 57. Asia Non-benzodiazepine Hypnotics Revenue Share by Type (2021-2032) Figure 58. Asia Non-benzodiazepine Hypnotics Sales Share by Type (2021-2032) Figure 59. Asia Non-benzodiazepine Hypnotics Revenue Share by Application (2021-2032) Figure 60. Asia Non-benzodiazepine Hypnotics Sales Share by Application (2021-2032) Figure 61. Asia Non-benzodiazepine Hypnotics Revenue Share by Country (2021-2032) Figure 62. Asia Non-benzodiazepine Hypnotics Sales Share by Country (2021-2032) Figure 63. SAMEA Non-benzodiazepine Hypnotics Revenue Share by Type (2021-2032) Figure 64. SAMEA Non-benzodiazepine Hypnotics Sales Share by Type (2021-2032) Figure 65. SAMEA Non-benzodiazepine Hypnotics Revenue Share by Application (2021-2032) Figure 66. SAMEA Non-benzodiazepine Hypnotics Sales Share by Application (2021-2032) Figure 67. SAMEA Non-benzodiazepine Hypnotics Revenue Share by Country (2021-2032) Figure 68. SAMEA Non-benzodiazepine Hypnotics Sales Share by Country (2021-2032) Figure 69. Non-benzodiazepine Hypnotics Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Non-benzodiazepine Hypnotics Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Zaleplon
  • Zopiclone
  • Zolpidem
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Abbott
  • Tianjin Tasly Saint Pharmaceuticals
  • Sun Pharmaceutical
  • Shanghai Pharmaceuticals
  • Qilu Pharmaceutical
  • Kanghong Pharmaceuticals
  • Changzhou Siyao Pharmaceutical
  • Wockhardt
  • Torrent Pharma
  • Teva Pharmaceuticals
  • Tapi Teva
  • Sanofi-aventis
  • Northstar Rx
  • Mylan Pharmaceuticals
  • Kanghong Pharmaceutical
  • Hikma Pharmaceuticals
  • Glenmark Life Sciences
  • Endo
  • Dr. Reddy’s Laboratories
  • Centaur Pharmaceuticals
  • Apotex
  • Admiron Life

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Non-benzodiazepine Hypnotics Market by Type
  3. 1.2.1 Global Non-benzodiazepine Hypnotics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Zaleplon
  5. 1.2.3 Zopiclone
  6. 1.2.4 Zolpidem
  7. 1.2.5 Other
  8. 1.3 Non-benzodiazepine Hypnotics Market by Application
  9. 1.3.1 Global Non-benzodiazepine Hypnotics Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Clinic
  12. 1.3.4 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Non-benzodiazepine Hypnotics Market Dynamics
  1. 2.1 Non-benzodiazepine Hypnotics Industry Trends
  2. 2.2 Non-benzodiazepine Hypnotics Industry Drivers
  3. 2.3 Non-benzodiazepine Hypnotics Industry Opportunities and Challenges
  4. 2.4 Non-benzodiazepine Hypnotics Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Non-benzodiazepine Hypnotics Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Non-benzodiazepine Hypnotics Revenue by Region
  3. 3.2.1 Global Non-benzodiazepine Hypnotics Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Non-benzodiazepine Hypnotics Revenue by Region (2021-2026)
  5. 3.2.3 Global Non-benzodiazepine Hypnotics Revenue by Region (2027-2032)
  6. 3.2.4 Global Non-benzodiazepine Hypnotics Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Non-benzodiazepine Hypnotics Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Non-benzodiazepine Hypnotics Sales by Region
  9. 3.4.1 Global Non-benzodiazepine Hypnotics Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Non-benzodiazepine Hypnotics Sales by Region (2021-2026)
  11. 3.4.3 Global Non-benzodiazepine Hypnotics Sales by Region (2027-2032)
  12. 3.4.4 Global Non-benzodiazepine Hypnotics Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Non-benzodiazepine Hypnotics Revenue by Manufacturers
  2. 4.1.1 Global Non-benzodiazepine Hypnotics Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Non-benzodiazepine Hypnotics Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Non-benzodiazepine Hypnotics Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Non-benzodiazepine Hypnotics Sales by Manufacturers
  6. 4.2.1 Global Non-benzodiazepine Hypnotics Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Non-benzodiazepine Hypnotics Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Non-benzodiazepine Hypnotics Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Non-benzodiazepine Hypnotics Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Non-benzodiazepine Hypnotics Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Non-benzodiazepine Hypnotics Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Non-benzodiazepine Hypnotics Manufacturers, Product Type & Application
  13. 4.7 Global Non-benzodiazepine Hypnotics Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Non-benzodiazepine Hypnotics Market CR5 and HHI
  16. 4.8.2 2025 Non-benzodiazepine Hypnotics Tier 1, Tier 2, and Tier 3
5 Non-benzodiazepine Hypnotics Market by Type
  1. 5.1 Global Non-benzodiazepine Hypnotics Revenue by Type
  2. 5.1.1 Global Non-benzodiazepine Hypnotics Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Non-benzodiazepine Hypnotics Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Non-benzodiazepine Hypnotics Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Non-benzodiazepine Hypnotics Sales by Type
  6. 5.2.1 Global Non-benzodiazepine Hypnotics Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Non-benzodiazepine Hypnotics Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Non-benzodiazepine Hypnotics Sales Market Share by Type (2021-2032)
  9. 5.3 Global Non-benzodiazepine Hypnotics Price by Type
6 Non-benzodiazepine Hypnotics Market by Application
  1. 6.1 Global Non-benzodiazepine Hypnotics Revenue by Application
  2. 6.1.1 Global Non-benzodiazepine Hypnotics Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Non-benzodiazepine Hypnotics Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Non-benzodiazepine Hypnotics Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Non-benzodiazepine Hypnotics Sales by Application
  6. 6.2.1 Global Non-benzodiazepine Hypnotics Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Non-benzodiazepine Hypnotics Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Non-benzodiazepine Hypnotics Sales Market Share by Application (2021-2032)
  9. 6.3 Global Non-benzodiazepine Hypnotics Price by Application
7 Company Profiles
  1. 7.1 Abbott
  2. 7.1.1 Abbott Company Information
  3. 7.1.2 Abbott Business Overview
  4. 7.1.3 Abbott Non-benzodiazepine Hypnotics Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Non-benzodiazepine Hypnotics Product Portfolio
  6. 7.1.5 Abbott Recent Developments
  7. 7.2 Tianjin Tasly Saint Pharmaceuticals
  8. 7.2.1 Tianjin Tasly Saint Pharmaceuticals Company Information
  9. 7.2.2 Tianjin Tasly Saint Pharmaceuticals Business Overview
  10. 7.2.3 Tianjin Tasly Saint Pharmaceuticals Non-benzodiazepine Hypnotics Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Tianjin Tasly Saint Pharmaceuticals Non-benzodiazepine Hypnotics Product Portfolio
  12. 7.2.5 Tianjin Tasly Saint Pharmaceuticals Recent Developments
  13. 7.3 Sun Pharmaceutical
  14. 7.3.1 Sun Pharmaceutical Company Information
  15. 7.3.2 Sun Pharmaceutical Business Overview
  16. 7.3.3 Sun Pharmaceutical Non-benzodiazepine Hypnotics Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sun Pharmaceutical Non-benzodiazepine Hypnotics Product Portfolio
  18. 7.3.5 Sun Pharmaceutical Recent Developments
  19. 7.4 Shanghai Pharmaceuticals
  20. 7.4.1 Shanghai Pharmaceuticals Company Information
  21. 7.4.2 Shanghai Pharmaceuticals Business Overview
  22. 7.4.3 Shanghai Pharmaceuticals Non-benzodiazepine Hypnotics Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Shanghai Pharmaceuticals Non-benzodiazepine Hypnotics Product Portfolio
  24. 7.4.5 Shanghai Pharmaceuticals Recent Developments
  25. 7.5 Qilu Pharmaceutical
  26. 7.5.1 Qilu Pharmaceutical Company Information
  27. 7.5.2 Qilu Pharmaceutical Business Overview
  28. 7.5.3 Qilu Pharmaceutical Non-benzodiazepine Hypnotics Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Qilu Pharmaceutical Non-benzodiazepine Hypnotics Product Portfolio
  30. 7.5.5 Qilu Pharmaceutical Recent Developments
  31. 7.6 Kanghong Pharmaceuticals
  32. 7.6.1 Kanghong Pharmaceuticals Company Information
  33. 7.6.2 Kanghong Pharmaceuticals Business Overview
  34. 7.6.3 Kanghong Pharmaceuticals Non-benzodiazepine Hypnotics Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Kanghong Pharmaceuticals Non-benzodiazepine Hypnotics Product Portfolio
  36. 7.6.5 Kanghong Pharmaceuticals Recent Developments
  37. 7.7 Changzhou Siyao Pharmaceutical
  38. 7.7.1 Changzhou Siyao Pharmaceutical Company Information
  39. 7.7.2 Changzhou Siyao Pharmaceutical Business Overview
  40. 7.7.3 Changzhou Siyao Pharmaceutical Non-benzodiazepine Hypnotics Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Changzhou Siyao Pharmaceutical Non-benzodiazepine Hypnotics Product Portfolio
  42. 7.7.5 Changzhou Siyao Pharmaceutical Recent Developments
  43. 7.8 Wockhardt
  44. 7.8.1 Wockhardt Company Information
  45. 7.8.2 Wockhardt Business Overview
  46. 7.8.3 Wockhardt Non-benzodiazepine Hypnotics Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Wockhardt Non-benzodiazepine Hypnotics Product Portfolio
  48. 7.8.5 Wockhardt Recent Developments
  49. 7.9 Torrent Pharma
  50. 7.9.1 Torrent Pharma Company Information
  51. 7.9.2 Torrent Pharma Business Overview
  52. 7.9.3 Torrent Pharma Non-benzodiazepine Hypnotics Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Torrent Pharma Non-benzodiazepine Hypnotics Product Portfolio
  54. 7.9.5 Torrent Pharma Recent Developments
  55. 7.10 Teva Pharmaceuticals
  56. 7.10.1 Teva Pharmaceuticals Company Information
  57. 7.10.2 Teva Pharmaceuticals Business Overview
  58. 7.10.3 Teva Pharmaceuticals Non-benzodiazepine Hypnotics Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Teva Pharmaceuticals Non-benzodiazepine Hypnotics Product Portfolio
  60. 7.10.5 Teva Pharmaceuticals Recent Developments
  61. 7.11 Tapi Teva
  62. 7.11.1 Tapi Teva Company Information
  63. 7.11.2 Tapi Teva Business Overview
  64. 7.11.3 Tapi Teva Non-benzodiazepine Hypnotics Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Tapi Teva Non-benzodiazepine Hypnotics Product Portfolio
  66. 7.11.5 Tapi Teva Recent Developments
  67. 7.12 Sanofi-aventis
  68. 7.12.1 Sanofi-aventis Company Information
  69. 7.12.2 Sanofi-aventis Business Overview
  70. 7.12.3 Sanofi-aventis Non-benzodiazepine Hypnotics Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Sanofi-aventis Non-benzodiazepine Hypnotics Product Portfolio
  72. 7.12.5 Sanofi-aventis Recent Developments
  73. 7.13 Northstar Rx
  74. 7.13.1 Northstar Rx Company Information
  75. 7.13.2 Northstar Rx Business Overview
  76. 7.13.3 Northstar Rx Non-benzodiazepine Hypnotics Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Northstar Rx Non-benzodiazepine Hypnotics Product Portfolio
  78. 7.13.5 Northstar Rx Recent Developments
  79. 7.14 Mylan Pharmaceuticals
  80. 7.14.1 Mylan Pharmaceuticals Company Information
  81. 7.14.2 Mylan Pharmaceuticals Business Overview
  82. 7.14.3 Mylan Pharmaceuticals Non-benzodiazepine Hypnotics Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Mylan Pharmaceuticals Non-benzodiazepine Hypnotics Product Portfolio
  84. 7.14.5 Mylan Pharmaceuticals Recent Developments
  85. 7.15 Kanghong Pharmaceutical
  86. 7.15.1 Kanghong Pharmaceutical Company Information
  87. 7.15.2 Kanghong Pharmaceutical Business Overview
  88. 7.15.3 Kanghong Pharmaceutical Non-benzodiazepine Hypnotics Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Kanghong Pharmaceutical Non-benzodiazepine Hypnotics Product Portfolio
  90. 7.15.5 Kanghong Pharmaceutical Recent Developments
  91. 7.16 Hikma Pharmaceuticals
  92. 7.16.1 Hikma Pharmaceuticals Company Information
  93. 7.16.2 Hikma Pharmaceuticals Business Overview
  94. 7.16.3 Hikma Pharmaceuticals Non-benzodiazepine Hypnotics Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Hikma Pharmaceuticals Non-benzodiazepine Hypnotics Product Portfolio
  96. 7.16.5 Hikma Pharmaceuticals Recent Developments
  97. 7.17 Glenmark Life Sciences
  98. 7.17.1 Glenmark Life Sciences Company Information
  99. 7.17.2 Glenmark Life Sciences Business Overview
  100. 7.17.3 Glenmark Life Sciences Non-benzodiazepine Hypnotics Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Glenmark Life Sciences Non-benzodiazepine Hypnotics Product Portfolio
  102. 7.17.5 Glenmark Life Sciences Recent Developments
  103. 7.18 Endo
  104. 7.18.1 Endo Company Information
  105. 7.18.2 Endo Business Overview
  106. 7.18.3 Endo Non-benzodiazepine Hypnotics Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Endo Non-benzodiazepine Hypnotics Product Portfolio
  108. 7.18.5 Endo Recent Developments
  109. 7.19 Dr. Reddy’s Laboratories
  110. 7.19.1 Dr. Reddy’s Laboratories Company Information
  111. 7.19.2 Dr. Reddy’s Laboratories Business Overview
  112. 7.19.3 Dr. Reddy’s Laboratories Non-benzodiazepine Hypnotics Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Dr. Reddy’s Laboratories Non-benzodiazepine Hypnotics Product Portfolio
  114. 7.19.5 Dr. Reddy’s Laboratories Recent Developments
  115. 7.20 Centaur Pharmaceuticals
  116. 7.20.1 Centaur Pharmaceuticals Company Information
  117. 7.20.2 Centaur Pharmaceuticals Business Overview
  118. 7.20.3 Centaur Pharmaceuticals Non-benzodiazepine Hypnotics Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Centaur Pharmaceuticals Non-benzodiazepine Hypnotics Product Portfolio
  120. 7.20.5 Centaur Pharmaceuticals Recent Developments
  121. 7.21 Apotex
  122. 7.21.1 Apotex Company Information
  123. 7.21.2 Apotex Business Overview
  124. 7.21.3 Apotex Non-benzodiazepine Hypnotics Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Apotex Non-benzodiazepine Hypnotics Product Portfolio
  126. 7.21.5 Apotex Recent Developments
  127. 7.22 Admiron Life
  128. 7.22.1 Admiron Life Company Information
  129. 7.22.2 Admiron Life Business Overview
  130. 7.22.3 Admiron Life Non-benzodiazepine Hypnotics Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Admiron Life Non-benzodiazepine Hypnotics Product Portfolio
  132. 7.22.5 Admiron Life Recent Developments
8 North America
  1. 8.1 North America Non-benzodiazepine Hypnotics Market Size by Type
  2. 8.1.1 North America Non-benzodiazepine Hypnotics Revenue by Type (2021-2032)
  3. 8.1.2 North America Non-benzodiazepine Hypnotics Sales by Type (2021-2032)
  4. 8.1.3 North America Non-benzodiazepine Hypnotics Price by Type (2021-2032)
  5. 8.2 North America Non-benzodiazepine Hypnotics Market Size by Application
  6. 8.2.1 North America Non-benzodiazepine Hypnotics Revenue by Application (2021-2032)
  7. 8.2.2 North America Non-benzodiazepine Hypnotics Sales by Application (2021-2032)
  8. 8.2.3 North America Non-benzodiazepine Hypnotics Price by Application (2021-2032)
  9. 8.3 North America Non-benzodiazepine Hypnotics Market Size by Country
  10. 8.3.1 North America Non-benzodiazepine Hypnotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Non-benzodiazepine Hypnotics Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Non-benzodiazepine Hypnotics Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Non-benzodiazepine Hypnotics Market Size by Type
  2. 9.1.1 Europe Non-benzodiazepine Hypnotics Revenue by Type (2021-2032)
  3. 9.1.2 Europe Non-benzodiazepine Hypnotics Sales by Type (2021-2032)
  4. 9.1.3 Europe Non-benzodiazepine Hypnotics Price by Type (2021-2032)
  5. 9.2 Europe Non-benzodiazepine Hypnotics Market Size by Application
  6. 9.2.1 Europe Non-benzodiazepine Hypnotics Revenue by Application (2021-2032)
  7. 9.2.2 Europe Non-benzodiazepine Hypnotics Sales by Application (2021-2032)
  8. 9.2.3 Europe Non-benzodiazepine Hypnotics Price by Application (2021-2032)
  9. 9.3 Europe Non-benzodiazepine Hypnotics Market Size by Country
  10. 9.3.1 Europe Non-benzodiazepine Hypnotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Non-benzodiazepine Hypnotics Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Non-benzodiazepine Hypnotics Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Non-benzodiazepine Hypnotics Market Size by Type
  2. 10.1.1 China Non-benzodiazepine Hypnotics Revenue by Type (2021-2032)
  3. 10.1.2 China Non-benzodiazepine Hypnotics Sales by Type (2021-2032)
  4. 10.1.3 China Non-benzodiazepine Hypnotics Price by Type (2021-2032)
  5. 10.2 China Non-benzodiazepine Hypnotics Market Size by Application
  6. 10.2.1 China Non-benzodiazepine Hypnotics Revenue by Application (2021-2032)
  7. 10.2.2 China Non-benzodiazepine Hypnotics Sales by Application (2021-2032)
  8. 10.2.3 China Non-benzodiazepine Hypnotics Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Non-benzodiazepine Hypnotics Market Size by Type
  2. 11.1.1 Asia Non-benzodiazepine Hypnotics Revenue by Type (2021-2032)
  3. 11.1.2 Asia Non-benzodiazepine Hypnotics Sales by Type (2021-2032)
  4. 11.1.3 Asia Non-benzodiazepine Hypnotics Price by Type (2021-2032)
  5. 11.2 Asia Non-benzodiazepine Hypnotics Market Size by Application
  6. 11.2.1 Asia Non-benzodiazepine Hypnotics Revenue by Application (2021-2032)
  7. 11.2.2 Asia Non-benzodiazepine Hypnotics Sales by Application (2021-2032)
  8. 11.2.3 Asia Non-benzodiazepine Hypnotics Price by Application (2021-2032)
  9. 11.3 Asia Non-benzodiazepine Hypnotics Market Size by Country
  10. 11.3.1 Asia Non-benzodiazepine Hypnotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Non-benzodiazepine Hypnotics Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Non-benzodiazepine Hypnotics Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Non-benzodiazepine Hypnotics Market Size by Type
  2. 12.1.1 SAMEA Non-benzodiazepine Hypnotics Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Non-benzodiazepine Hypnotics Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Non-benzodiazepine Hypnotics Price by Type (2021-2032)
  5. 12.2 SAMEA Non-benzodiazepine Hypnotics Market Size by Application
  6. 12.2.1 SAMEA Non-benzodiazepine Hypnotics Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Non-benzodiazepine Hypnotics Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Non-benzodiazepine Hypnotics Price by Application (2021-2032)
  9. 12.3 SAMEA Non-benzodiazepine Hypnotics Market Size by Country
  10. 12.3.1 SAMEA Non-benzodiazepine Hypnotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Non-benzodiazepine Hypnotics Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Non-benzodiazepine Hypnotics Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Non-benzodiazepine Hypnotics Value Chain Analysis
  2. 13.1.1 Non-benzodiazepine Hypnotics Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Non-benzodiazepine Hypnotics Production Mode & Process
  6. 13.2 Non-benzodiazepine Hypnotics Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Non-benzodiazepine Hypnotics Distributors
  9. 13.2.3 Non-benzodiazepine Hypnotics Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst